Toni Choueiri, MD, Professor of Medicine at Harvard Medical School, prolific researcher with hundreds of peer-reviewed articles in the most prestigious journals in the world, a kidney cancer specialist at the Dana-Farber Cancer Institute, and Director of the GU oncology program there, sits with me to discuss surgical considerations and multidisciplinary care for localized kidney cancer, adjuvant therapies largely falling short of expectations, and the plethora of frontline therapies available in metastatic disease.
No one in the world knows kidney cancer like Toni does, so let’s spend 50 minutes learning from him.